XML 32 R16.htm IDEA: XBRL DOCUMENT v2.3.0.15
Stockholders' Equity
9 Months Ended
Sep. 30, 2011
Stockholders' Equity [Abstract] 
STOCKHOLDERS' EQUITY
NOTE 10 — STOCKHOLDERS’ EQUITY
STOCK ISSUANCES
On January 25, 2011 the Company issued 320,000 shares of its common stock to a consultant satisfying a $1,344,000 accrual for services rendered in connection with the settlement of certain Woodbridge obligations.
On February 23, 2011, the Company issued 216,500 restricted shares at $3.70 (the closing price as of the date of issuance) to certain employees under the Amended and Restated 2006 Stock Option Plan. The statement of operations and comprehensive loss for the nine month period ended September 30, 2011 includes a charge of $801,050 for this compensation.
During April 2011, the Company issued 290,070 shares of its common stock as compensation under its stock option plan. These shares were issued to employees and directors and are restricted for a period of two years from issuance. The Company recorded compensation expense of $756,775 in its statement of operations and comprehensive loss for the nine month period ended September 30, 2011, based upon the closing price of the shares on the commitment date.
On June 20, 2011, the Company issued 776,980 shares of its common stock in exchange for the return of 4,219 shares of its preferred stock.
On June 10, 2011, the Company issued 50,833 shares of its common stock to vendors for services. The shares are restricted for a period of six months. The Company reduced the vendor payables by $76,250 based upon the closing price of the shares on the commitment date.
During the nine month period ended September 30, 2011 the Company issued 4,029,373 shares of its common stock as loan repayments which reduced the balance on the convertible notes by $6,412,957.
WARRANTS
In addition to the warrants classified as derivatives, the Company has also recognized certain warrants as equity instruments.
The following table sets forth the outstanding warrants classified as equity instruments as of September 30, 2011:
                                                         
            Outstanding                             Outstanding     Exercisable  
            at                             at     at  
            December 31,                             September 30,     September 30,  
Warrants   Price     2010     Issued     Exercised     Canceled     2011     2011  
Class B
  $ 110.00       264,803                         264,803       264,803  
Class E
  $ 16.30       150,000                         150,000       150,000  
Class F
  $ 0.50       58,500                         58,500       58,500  
Class H
  $ 13.00       1,725,000                         1,725,000       1,725,000  
Class J
  $ 5.40       162,333                         162,333       162,333  
Class K
  $ 5.40       115,741                         115,741       115,741  
In the event all outstanding warrants are exercised, including those classified as derivatives and those classified as equity, the Company has adequate shares authorized to meet these obligations.
In August 2011, the Company amended certain provisions of its April 2011 convertible note financing and as a result the Class F Warrants listed above were repriced from $10.25 to $0.50. The Company recorded a charge in its statement of operations for the three months ended September 30, 2011 of $17,333 associated with the modification.
STOCK OPTIONS
During the nine month period ended September 30, 2011, the Company issued 317,570 stock options to employees and directors under its stock option plan. The Company calculated a compensation expense associated with the issuance of these options of $699,444 using the Black-Scholes pricing model. The Company assumed a five year term, risk free interest rate of 1.9%, average volatility of 113.6% and exercise prices of $1.50 to $2.70.
Stock option activity for the nine month period ended September 30, 2011 is as follows:
                         
            Weighted     Weighted  
            Average     Average  
            Exercise     Remaining  
    Stock     Price per     Life  
    Options     Share     (Years)  
Outstanding and exercisable at December 31, 2010
    364,380     $ 16.40       8.8  
Granted
    282,802       2.70          
Granted
    21,868       2.20          
Granted
    12,900       1.50          
Forfeited
    (2,400 )     6.10          
 
                     
 
                       
Outstanding and exercisable at September 30, 2011
    679,550     $ 10.00       8.2